Chronisch obstruktive Lungenerkrankung (COPD)

Schlüsselwörter

chronisch obstruktive Lungenerkrankung (COPD) - Inflammation - Training - Roflumilast - Salmeterol - Tiotropiumbromid

Keywords

COPD - inflammation - training - roflumilast - salmeterol - tiotropiumbromid

• Literatur

• 1 Bateman ED, Rabe KF, Calverley PM et al. Roflumilast with long-acting beta2-agonists for COPD: influence of exacerbation history. Eur Respir J 2011; 38: 553
• 2 Gloeckl R, Heinzelmann I, Baeuerle S et al. Effects of whole body vibration in patients with chronic obstructive pulmonary disease – a randomized controlled trial. Respir Med 2012; 106: 75
• 3 GOLD. The Global initiative for chronic Obstructive Lung disease. www.goldcopd.org
• 4 Hattesohl AD, Jorres RA, Dressel H et al. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Respirology 2011; 16: 1258
• 5 Koczulla AR, Hattesohl A, Biller H et al. [Smelling diseases? A short review on electronic noses]. Pneumologie 2011; 65: 401
• 6 Macchia A, Rodriguez Moncalvo JJ, Kleinert M et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39: 51
• 7 Nici L, Lareau S, ZuWallack R. Pulmonary rehabilitation in the treatment of chronic obstructive pulmonary disease. Am Fam Physician 2010; 82: 655
• 8 Vogelmeier C, Hederer B, Glaab T et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093
• 9 Yoon H, Li Y, Man SF et al. The complex relationship of serum adiponectin to COPD outcomes. Chest 2011; Dec 29. [Epub ahead of print]